Yw. Li et Pg. Guyenet, NEURONAL INHIBITION BY A GABA(B) RECEPTOR AGONIST IN THE ROSTRAL VENTROLATERAL MEDULLA OF THE RAT, American journal of physiology. Regulatory, integrative and comparative physiology, 37(2), 1995, pp. 428-437
We recorded the effects of the gamma-aminobutyric acid class B (GABA(B
)) receptor agonist baclofen on neuronal activity in the rat rostral v
entrolateral medulla (RVLM) in tissue slices and in vivo. In vitro, ba
clofen (3 mu M) produced hyperpolarization (13 of 17), decrease in inp
ut resistance (12 of 16), and reduction of spontaneous synaptic activi
ty (7 of 14). Baclofen inhibited 84 of 87 spontaneously active neurons
recorded extracellularly in vitro. Inhibition was concentration depen
dent (0.1-3 mu M, maximum inhibition: 94 +/- 4%, n = 16) and persisted
in low-Ca2+/high-Mg2+ medium (n = 19). The GABA(B) receptor antagonis
ts CGP-54626A (1 mu M, n = 19), CGP-55845A(1 mu M, n = 15), and 2-hydr
oxysaclofen (0.5 mM, n = 3) attenuated inhibition by baclofen (1-3 mu
M) but not by muscimol or GABA. In vivo, iontophoresis of baclofen inh
ibited 31 of 32 RVLM neurons, including bulbospinal barosensitive (15
of 16) and respiratory ones (7 of 7). CGP-55845A attenuated baclofen i
nhibition (6 of 9). Bicuculline attenuated the effect of GABA but not
that of baclofen (4 of 4). In summary, RVLM presympathetic neurons hav
e somatodendritic GABA(B) receptors that may contribute to baclofen-in
duced hypotension in humans.